By Suvarna Bhatt
San Francisco, February 24 (BioSpace) - Cambridge Laboratories announces the European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP) has given a positive opinion for its product, Valtropin(TM).
Valtropin(TM ) is a similar biological medicinal product containing recombinant human growth hormone.
Contact Suvarna Bhatt at sbhatt@biospace.com.
